AGC Biologics 보도자료

• AGC Biologics Supports Commercial Production of Provention Bio's New Type 1 Diabetes (T1D) Therapy, TZIELD™ 2023-01-25 15:35
• AGC Biologics, Provention Bio의 새로운 제1형 당뇨병(T1D) 치료제 TZIELD™의 상업 생산 지지 2023-01-25 15:35